|
|
|
World Trade Group, Cologne, Germany
5th - 6th December 2006
The 6th Annual World Drug Discovery & Development Summit brings together over 300 leading pharmaceutical and biotech professionals to discuss the key scientific and strategic challenges faced by the industry today. WDD 2006 focuses on how companies can reduce attrition and improve productivity through enabling and predictive technologies; supported by industry led case studies from leading pharmaceutical companies.
|
|
|
|
|
|
Organized by:
|
|
World Trade Group |
|
Invited Speakers:
|
|
Dr Hanno Wild, Senior Vice President Discovery Europe, Pharma Global Drug Discovery, Bayer HealthCare AG Prof. Ian Wilson, Senior Principal Scientist, AstraZeneca Dr Graham Dixon, Senior Vice President, Drug Discovery, Galapagos NV Dr Frank Sams-Dodd, Vice President, Preclinical Development, Bionomics Peter O’ Brien, Head of Discovery Toxicology Biomarkers, Pfizer Dr Jeffrey Waring, Group Leader, Toxiocogenomics, Abbott Laboratories Dr Irina Antonijevic, Director, Translational Research , Lundbeck Research Dr Frank Büttner, Department of Lead Discovery, Boehringer-Ingelheim Dr Dan Burns, Senior Vice President, Pharmacogenetics, GlaxoSmithKline Peter O’ Brien, Head of Discovery Toxicology Biomarkers, Pfizer Dr Jan ter Meulen, Executive Director, Infectious Diseases, Crucell
|
|
|
|
|
|
Deadline for Abstracts:
|
|
none
|
|
|
|
|
|
Registration:
|
|
www.wddsummit.com + 44 (0)20 7940 5547
|
|
E-mail:
|
|
lisa.wulf@worldtradeco.com
|
|
|
|
|
|
|
|